SE1 (ASX) Time for some good news

Originally posted by Quiltman: ↑

Based on the fact many of us have short memories, and there could be some new potential investors on this thread, I thought it may be relevant to repost part of an old post from @sailorlion that related to the patent on our sensor related to our involvement with NanoDX. This is the piece of the puzzle that irrevocably ties Sensera to NanoDiagnostics.

.....

am very very happy about the below exclusive patents owned by Sensera, which also relates to the techonology

Sensera holdsexclusive patents from the US Department of Navy (DoD), Nanoporous membrane immunosensor as one of the Sensera technologies seems very similar to the technology being deployed with the Nanodx range of products

Theexclusive patentscertainly put Sensera inpole position to deploy such technologies in the fields of

Microfluidics,
Point of Care diagnostics, (NanoDX ??)
Labs-On-Chips
and Organs-on-Chips

According to below announcement, basically anything that can be detected throughNucleic acid, DNA, RNA and proteins.
- Detection of Sepsis is through elevated protein such as interleukin-6 (IL-6).
- Influenza would be through RNA molecules,
- HIV can be detected through DNA or RNA,
- Dengue fever would also be RNA etc.

So basically all RNA and DNA family viruses can be tested by this technology under Sensera.

All above are persional view based on personal understanding, DYOR

Expand

I think there is some confusion between the owning of a patent and being granted licensing rights. From what I could see SE1 have one patent for a Compact Gas Sensor but no patents owned by them in microfluidics, labonachip or organonachip. These are owned by Wyss with SE1 developing their own IP to compliment them.

”Revocable and non assignable” granted to Sensera in 2003 (?) by the Department of the Navy.

This also begs the question that if a take-over offer was to come into play then would the licences held by SE1 be permitted to be transferred to néw ownership ?

I’m not sure the citing of “exclusive patents” “owned by Sensera” is an entirely accurate statement.

I’d be pleased to have it demonstrated otherwise.